Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target raised by investment analysts at Citigroup from $51.00 to $57.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target indicates a potential upside of 159.03% from the stock’s previous close. [...]
(The Center Square) – A bipartisan group of U.S. senators is seeking to unite Democrats and Republicans in a collaborative effort to talk about the nation's unsustainable debt. Read Full Article →
Minnesota lawmakers are considering a total ban on cryptocurrency ATMs to combat a surge in scams. While police say the kiosks are magnets for fraud, owners argue a ban goes too far. Read Full Article →
RiverStone Health CEO Jon Forte and legal counsel for the Colonial’s estate called the request to halt demolition by a Billings resident, “attempted interference.” Read Full Article →
U.S. President Donald Trump announced on Tuesday the opening of an oil refinery in Brownsville, Texas, saying it was a $300 billion deal and thanking Indian energy company Reliance for its... Read Full Article →
